https://www.theaustralian.com.au/business/*/incannex-gets-green-light-from-us-fda-for-phase-23-pivotal-clinical-trialfor-obstructive-sleep-apnoea/news-story/2b1b7ee48bcd68faec7df50612889b11
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint